BRPI0706709B8 - composição e processo para preparar a composição - Google Patents

composição e processo para preparar a composição

Info

Publication number
BRPI0706709B8
BRPI0706709B8 BRPI0706709A BRPI0706709A BRPI0706709B8 BR PI0706709 B8 BRPI0706709 B8 BR PI0706709B8 BR PI0706709 A BRPI0706709 A BR PI0706709A BR PI0706709 A BRPI0706709 A BR PI0706709A BR PI0706709 B8 BRPI0706709 B8 BR PI0706709B8
Authority
BR
Brazil
Prior art keywords
composition
adjuvant
preparing
compositions
solutions
Prior art date
Application number
BRPI0706709A
Other languages
English (en)
Inventor
Joseph Dominowski Paul
Mannar Mannan Ramasamy
Mediratta Sangita
Original Assignee
Pah Usa 15 Llc
Pfizer Prod Inc
Zoetis P Llc
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pah Usa 15 Llc, Pfizer Prod Inc, Zoetis P Llc, Zoetis Services Llc filed Critical Pah Usa 15 Llc
Publication of BRPI0706709A2 publication Critical patent/BRPI0706709A2/pt
Publication of BRPI0706709B1 publication Critical patent/BRPI0706709B1/pt
Publication of BRPI0706709B8 publication Critical patent/BRPI0706709B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18651—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

composições de adjuvantes glicolipidios esta invençào está relacionada a composições e métodos de preparar soluções estoques estáveis diluentes de adjuvantes e soluções adjuvantes finais compreendendo glicolipídios, ácidos fracos, álcoois, tensoativos nâo-iônicos e tampões.
BRPI0706709A 2006-01-26 2007-01-15 composição e processo para preparar a composição BRPI0706709B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US76227906P 2006-01-26 2006-01-26
US60/762,279 2006-01-26
US81498406P 2006-06-20 2006-06-20
US60/814,984 2006-06-20
PCT/IB2007/000258 WO2007085962A2 (en) 2006-01-26 2007-01-15 Novel glycolipid adjuvant compositions

Publications (3)

Publication Number Publication Date
BRPI0706709A2 BRPI0706709A2 (pt) 2011-04-05
BRPI0706709B1 BRPI0706709B1 (pt) 2021-03-23
BRPI0706709B8 true BRPI0706709B8 (pt) 2021-05-25

Family

ID=38309580

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0706709A BRPI0706709B8 (pt) 2006-01-26 2007-01-15 composição e processo para preparar a composição

Country Status (21)

Country Link
US (1) US8460679B2 (pt)
EP (2) EP1991266B1 (pt)
JP (1) JP5538725B2 (pt)
KR (2) KR101202553B1 (pt)
AR (1) AR059192A1 (pt)
AU (1) AU2007209104B2 (pt)
BR (1) BRPI0706709B8 (pt)
CA (1) CA2634888C (pt)
CY (1) CY1114310T1 (pt)
DK (1) DK1991266T3 (pt)
ES (1) ES2425576T3 (pt)
HK (1) HK1128078A1 (pt)
ME (3) ME01545B (pt)
NO (1) NO341463B1 (pt)
NZ (1) NZ569375A (pt)
PL (1) PL1991266T3 (pt)
PT (1) PT1991266E (pt)
RS (2) RS52930B (pt)
RU (1) RU2392965C2 (pt)
TW (1) TWI372631B (pt)
WO (1) WO2007085962A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008000261A2 (en) * 2006-06-28 2008-01-03 Statens Serum Institut Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
ES2728949T3 (es) * 2008-06-27 2019-10-29 Zoetis Services Llc Composiciones adyuvantes novedosas
EP2337582A1 (en) 2008-10-03 2011-06-29 Novartis AG Bovine herpes virus -1 compositions, vaccines and methods
WO2014141127A1 (en) * 2013-03-15 2014-09-18 Glaxosmithkline Biologicals S.A. Composition containing buffered aminoalkyl glucosaminide phosphate derivatives and its use for enhancing an immune response
WO2015042369A2 (en) 2013-09-19 2015-03-26 Zoetis Llc Oil-based adjuvants
CA2932878C (en) 2013-11-26 2020-11-03 Zoetis Services Llc Compositions for induction of immune response
PL3244920T3 (pl) 2015-01-16 2023-09-25 Zoetis Services Llc Szczepionka przeciw pryszczycy
ES2878475T3 (es) * 2015-07-20 2021-11-18 Zoetis Services Llc Composiciones adyuvantes liposomales
GB201703529D0 (en) 2017-03-06 2017-04-19 Cambridge Entpr Ltd Vaccine composition
CN110713520B (zh) * 2019-11-06 2021-01-01 中国石油天然气股份有限公司 油酰基氨基酸-γ-L-谷氨酰-L-半胱氨酰-甘氨酸多肽及其制备与应用
TW202206098A (zh) 2020-08-11 2022-02-16 美商碩騰服務公司 抗冠狀病毒疫苗
WO2022072431A1 (en) 2020-09-30 2022-04-07 Zoetis Services Llc Novel pasteurella multocida strains and vaccines having hyac and nanp deletions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291019A (en) * 1979-07-09 1981-09-22 Iowa State University Research Foundation, Inc. Vaccine for infectious bovine rhinotracheitis
DE3213650A1 (de) 1982-04-14 1983-10-27 Bayer Ag, 5090 Leverkusen N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr
DE3403495A1 (de) 1983-11-23 1985-05-30 Bayer Ag, 5090 Leverkusen Phosphorylierte glycosylamide, -harnstoffe, -carbamate und -thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3346623A1 (de) 1983-12-14 1985-07-04 Bayer Ag, 5090 Leverkusen N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3521994A1 (de) 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
US6764682B1 (en) 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
FI109332B (fi) * 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
BR0114392A (pt) * 2000-10-02 2003-09-02 Glaxosmithkline Biolog Sa Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv

Also Published As

Publication number Publication date
JP5538725B2 (ja) 2014-07-02
CY1114310T1 (el) 2016-08-31
WO2007085962A2 (en) 2007-08-02
ES2425576T3 (es) 2013-10-16
RU2008129203A (ru) 2010-03-10
EP1991266A2 (en) 2008-11-19
RS52930B (en) 2014-02-28
BRPI0706709A2 (pt) 2011-04-05
AR059192A1 (es) 2008-03-12
ME01545B (me) 2014-04-20
HK1128078A1 (en) 2009-10-16
RU2392965C2 (ru) 2010-06-27
NO20083405L (no) 2008-10-23
PL1991266T3 (pl) 2013-11-29
NZ569375A (en) 2010-05-28
CA2634888A1 (en) 2007-08-02
EP1991266B1 (en) 2013-06-26
JP2009524638A (ja) 2009-07-02
US8460679B2 (en) 2013-06-11
CA2634888C (en) 2016-06-21
TWI372631B (en) 2012-09-21
MEP4508A (en) 2010-06-10
PT1991266E (pt) 2013-08-28
BRPI0706709B1 (pt) 2021-03-23
DK1991266T3 (da) 2013-08-26
WO2007085962A3 (en) 2007-12-27
US20070196384A1 (en) 2007-08-23
KR101202553B1 (ko) 2012-11-20
AU2007209104B2 (en) 2010-04-08
TW200738268A (en) 2007-10-16
ME00045B (me) 2010-10-10
EP2481423A1 (en) 2012-08-01
AU2007209104A1 (en) 2007-08-02
NO341463B1 (no) 2017-11-20
KR20110140140A (ko) 2011-12-30
RS20080318A (en) 2009-05-06
KR20080080223A (ko) 2008-09-02

Similar Documents

Publication Publication Date Title
BRPI0706709B8 (pt) composição e processo para preparar a composição
CL2011003113A1 (es) Composicion adyuvante acuosa que comprende un agonista de tlr-4 y una saponina y un agente de isotonicidad no ionico; proceso para la preparacion de una composicion inmunogenica.
BRPI0922333A2 (pt) processo de produção de um artigo para dissolução mediante o uso da aplicação de tensoativos
SMT201700092B (it) Processo per la preparazione di composti utili come inibitori di sglt
GT201000211A (es) Procesos e intermediarios para la preparación de derivados de acido 5-bifenil-a-il-2-metilpentanoico
UY30701A1 (es) Sistemas espesados con surfactantes, compuestos de celulosa micro fibrosa, y metodos para fabricarlos
BRPI0915728A2 (pt) composição enzimática, processo para preparar a composição, uso da composição enzimática, e, composição detergente.
BRPI0507862A (pt) processo para a alcoxilação de alquil- e/ou alquenilpoliglicosìdeos
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
BR112015029254A2 (pt) composição detergente de baixo ph compreendendo tensoativos não iônicos
BRPI0912391A2 (pt) processo para produção de óxido de olefina, 1,2-diol éter, 1,2-carbonato, ou alcanolamina
BR112014005190A2 (pt) composições em microcápsula compreendendo gelificantes de di-amido ajustáveis por ph
BRPI1007177A2 (pt) processo para a fabricação de composições de fertilizante contendo enxofre, composição de fertilizante, e, uso de um tensoativo aniônico.
WO2010108756A3 (de) Wässrige haar- und hautreinigungszusammensetzungen
MX340322B (es) Desinfectante de amplio espectro.
BRPI0917442A2 (pt) composições compreendendo tensoativo e microcápsulas, processo para o tratamento de superfícies, e, método para preparar composições
BRPI0719264B8 (pt) processo para a preparação de nebivolol
BRPI0811282A2 (pt) Processo para a produção de um óxido de olefina, um 1,2-diol, um 1,2-diol éter, um 1,2-carbonato, ou uma alcanolamina
UA90569C2 (ru) Композиция гликолипидного адьюванта (варианты) и способ ее получения
BRPI0622035A2 (pt) Processo para preparação do éter clorometil 2,2,2-trifluoro-1-(trifluorometil) etílico
BRPI0716080A2 (pt) processo para produÇço de Ácidos (aminofosfinil) butanàicos oticamente ativos
BRPI0909695A2 (pt) processo para a preparação de nebivolol
AR075299A1 (es) Formulacion con tendencias de formacion reducida de geles y metodo para reducir la tendencia de formacion de geles
GT200600010A (es) Procedimientos para la preparacion de alcoholes aminoetoxibencilicos
FR2890879B1 (fr) Procede de fabrication de pieces creuses telles que des aubes de turbomachine.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH USA 15 LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS P LLC (US)

B25C Requirement related to requested transfer of rights

Owner name: ZOETIS P LLC (US)

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 860150304717 DE 23/12/2015, E NECESSARIO E NECESSARIO APRESENTAR A TRADUCAO JURAMENTADA DO DOCUMENTO DE CESSAO, CONFORME ART. 18 DO DEC. 13.609/43.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B25G Requested change of headquarter approved

Owner name: ZOETIS SERVICES LLC (US)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/01/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF